Diabetic Neuropathy News and Research

RSS
Diabetic neuropathy is a peripheral nerve disorder caused by diabetes or poor blood sugar control. The most common types of diabetic neuropathy result in problems with sensation in the feet. It can develop slowly after many years of diabetes or may occur early in the disease. The symptoms are numbness, pain, or tingling in the feet or lower legs. The pain can be intense and require treatment to relieve the discomfort. The loss of sensation in the feet may also increase the possibility that foot injuries will go unnoticed and develop into ulcers or lesions that become infected. In some cases, diabetic neuropathy can be associated with difficulty walking and some weakness in the foot muscles. There are other types of diabetic-related neuropathies that affect specific parts of the body. For example, diabetic amyotrophy causes pain, weakness and wasting of the thigh muscles, or cranial nerve infarcts that may result in double vision, a drooping eyelid, or dizziness. Diabetes can also affect the autonomic nerves that control blood pressure, the digestive tract, bladder function, and sexual organs. Problems with the autonomic nerves may cause lightheadedness, indigestion, diarrhea or constipation, difficulty with bladder control, and impotence.
Chronic nerve pain: an interview with Professor Sally Lawson

Chronic nerve pain: an interview with Professor Sally Lawson

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

RegeneRx’s Thymosin Beta 4 can promote recovery of diabetic peripheral neuropathy

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Positive results from Spinifex’s EMA401 Phase 2 trial on postherpetic neuralgia

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

Hint of tafamidis benefit in rare polyneuropathy

Hint of tafamidis benefit in rare polyneuropathy

Folic acid ‘may benefit diabetics’

Folic acid ‘may benefit diabetics’

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Controlled blood sugar in diabetes can prevent painful nerves: but at what cost?

Controlled blood sugar in diabetes can prevent painful nerves: but at what cost?

Vibrating device aids diabetic neuropathy foot screening

Vibrating device aids diabetic neuropathy foot screening

New study into pain associated with diabetes

New study into pain associated with diabetes

Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients

Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients

Insight into why diabetics suffer from increased pain and temperature sensitivity

Insight into why diabetics suffer from increased pain and temperature sensitivity

EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN

EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN

Converted umbilical cord stem cells hold hope for spinal cord injuries, multiple sclerosis

Converted umbilical cord stem cells hold hope for spinal cord injuries, multiple sclerosis

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

IQWiG identifies additional recommendations for diabetes mellitus type 2 DMP

IQWiG identifies additional recommendations for diabetes mellitus type 2 DMP

EC approves Pfizer's Vyndaqel to treat Transthyretin Familial Amyloid Polyneuropathy

EC approves Pfizer's Vyndaqel to treat Transthyretin Familial Amyloid Polyneuropathy

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.